MaryO

Ok...toll-free number added, but I don't know how legible it is

I was going to, and I might add it later, but I'm having trouble geting volunteers to answer it. You know I can't do that all the time...or often

Here's the front and back of most of them. http://www.cafeshops.com/cp....es#zoom Some have the front centered, and some are over to the side. Some, like the golf shirt and the baseball shirt are front only. The baseball one has black, red or blue sleeves.

T-shirts are now here! See them at http://www.cafeshops.com/cp/store.aspx?s=cushings Size Chart Jr. Baby Doll T-shirts Small (0-2) Medium (2-6) Large (6-12) T-shirt, Long Sleeve, Sweatshirt, Tank Tops Small (34-36) Medium (38-40) Large (42-44) X-large (46-48) 2X-large (50-52) 3X-large (54-56) 4X-large (58-60) Each provides $1 profit to CUSH and $1 for the running of these boards and websites. Available are: White T-Shirt, $15.99 each, Perfect for wearing to the Convention! Product Number: 1853115 In Stock: Will ship in 2-3 business days. Product Information: The most comfortable t-shirt ever! Our 100% cotton, Hanes Beefy-T is preshrunk, durable and guaranteed. 6.1 oz. fabric - luxuriously soft 100% cotton ring-spun yarn Double-needle coverseamed neck Taped shoulder-to-shoulder Double needle sleeve and bottom hems Our printing is better than ever ? full of detail and color ? and virtually fade resistant wash after wash. Jr. Baby Doll T-Shirt, $16.99 each Product Information: Our super soft 100% combed cotton, ribbed baby doll T-shirt from American Apparel will keep you in style. Special details include 1/2" binding on neck and sleeve with 1" bottom hem. Size Note: Small fits women sizes 0-2, medium fits women sizes 2-6, and large fits women sizes 6-12. Our printing is better than ever ? full of detail and color ? and virtually fade resistant wash after wash. Tank Top, $15.99 each Product Information: When the temperature rises, our 100% cotton Hanes Tank Top will help keep you cool. Preshrunk, durable and guaranteed. 5.5 oz. fabric made with 100% cotton open-end yarn Durable binding around the neck and armholes prevents stretching Double-needle bottom hem Preshrunk to minimize shrinkage Our printing is better than ever ? full of detail and color ? and virtually fade resistant wash after wash. Ladies Tank Top, $15.99 each Product Number: 2691569 In Stock: Will ship in 2-3 business days. Product Information: Always in style, our 100% cotton ladies tank top from Anvil will keep you cool when the temperature rises. Preshrunk, durable and guaranteed. Pre-shrunk heavyweight 5.6 oz. 100% cotton. Fashion cut for ladies. Bound-on rib around neck and armhole. Double needle bottom hem. Golf Shirt, $18.99 each The back is blank. Product Number: 2691576 In Stock: Will ship in 2-3 business days. Product Information: The perfect casual wear for the office, our Anvil golf shirts are made of 100% preshrunk, heavyweight cotton. Soft fashion knit collar and rib sleeve bands. Two woodtone buttons on a clean finished placket with 1/4" reinforced box. Double needle bottom hem. 5.6 oz preshrunk heavyweight cotton Knit collar Banded sleeves Two woodtone buttons Baseball Jersey, $18.99 each No image on the back Product Number: 2691591 In Stock: Will ship in 2-3 business days. Product Information: Our 100% Cotton Baseball Jerseys are popular with both men and women. Choose either Red or Black sleeves. 100% Preshrunk Cotton 5.9 oz Jersey (Tubular) ? Raglan Sleeves Double Needle Sleeves Our printing is better than ever ? full of detail and color ? and virtually fade resistant wash after wash. Long Sleeve T-Shirt, $20.99 each Product Number: 2691608 In Stock: Will ship in 2-3 business days. The most comfortable t-shirt ever! Our 100% cotton, Hanes Beefy-T is preshrunk, durable and guaranteed. 6.1 oz. fabric ? luxuriously soft 100% cotton ring-spun yarn Double-needle coverseamed neck Taped shoulder-to-shoulder Double needle sleeve and bottom hems Our printing is better than ever ? full of detail and color ? and virtually fade resistant wash after wash. Sweatshirt $22.99 each For the winter Product Number: 2691617 In Stock: Will ship in 2-3 business days. Product Information: Stay warm with our Hanes Heavyweight 50/50 cotton/polyester sweatshirts. Thick (but not bulky), comfortable, durable and guaranteed. 9 oz. patented PrintPro? fabric in a 50/50 cotton/polyester blend Double-needle coverseamed collars, armholes and waistband Densely knit fabric for a smooth printing and embroidery surface Spandex trim in the neck, cuffs and waistband Preshrunk to minimize shrinkage Our printing is better than ever ? full of detail and color ? and virtually fade resistant wash after wash.

http://story.news.yahoo.com/news?tm....ne_dc_1 NEW YORK (Reuters Health) - The image of hormone replacement therapy, battered by last week's revelation that the risks can outweigh the benefits in the long term, received another blow from researchers on Tuesday. They report that women who take estrogen-only hormone replacement therapy (HRT) for a long period of time have a higher-than-average risk of developing ovarian cancer. However, Dr. James V. Lacey, Jr. and his colleagues at the National Cancer Institute in Rockville, Maryland found that women who take short rounds of estrogen that is combined with progestin seem to have no higher risk of ovarian cancer than women who have never taken HRT. Typically, only women who have had their uterus removed take estrogen alone because the hormone is known to increase the risk of cancer of the uterine lining. Women who have a uterus take estrogen in combination with progestin, which cuts the cancer risk. In an interview with Reuters Health, Lacey stressed that these results only suggest a link between ovarian cancer and estrogen replacement therapy and do not prove that ovarian cancer is a direct result of the estrogen. Previous research into long-term use of estrogen did not connect it with an increased risk of ovarian cancer, the authors note, which demonstrates how easily the state of knowledge can change. Given the recent report that estrogen/progestin combinations can increase the risk of heart disease and breast cancer when taken for more than 4 years, the choice of whether or not to take HRT can be quite complicated, Lacey added. That study found that estrogen/progestin decreased the risk of colon cancer and hip fractures, but the risks of other problems outweighed the benefits. A second study due in 2005 will determine if estrogen alone increases the risk of heart disease and breast cancer. "Because hormone therapy may influence so many conditions that affect women after menopause--cardiovascular disease, osteoporosis, breast cancer, uterine cancer, gallbladder disease, blood clots, and now potentially ovarian cancer--we should no longer think of a woman basing her decision to use hormones on the potential risk of just one condition," he said. While millions of women choose HRT to reduce menopausal symptoms, many used it as a preventative therapy to reduce their risk of heart disease or the bone-thinning condition osteoporosis. The findings, reported in the July 17th issue of The Journal of the American Medical Association, are based on a follow-up of 44,241 women who began taking HRT when they were an average of 57 years old. Some of the women had a hysterectomy but still had one or both of their ovaries. During the study period, 329 women developed ovarian cancer. Women who took estrogen for longer periods of time had a higher risk of the disease, and the researchers noted a 7% increase in risk associated with every extra year of estrogen use. Those who took estrogen for at least 10 years were twice as likely to develop ovarian cancer and those who used the drugs for 20 or more years were three times as likely to develop ovarian cancer as those who did not take the hormone, the report indicates. An important caveat, Lacey and his team note, is that this study included women who began taking HRT in the 1970s, when the therapies contained higher doses of estrogen than what is in use today. "Whether long-term use of lower-dose estrogen replacement therapy increases the risk of ovarian cancer is not known," they write. Women who took estrogen/progestin alone, or after using estrogen alone, appeared to be no more likely to develop ovarian cancer than women who did not take hormones, the study reports. However, the jury is still out on whether estrogen/progestin combinations can have an impact on ovarian cancer risk, the authors note. "This recent emergence of an increased risk (of ovarian cancer) in long-term (estrogen) users should remind investigators that it is premature to conclude that estrogen/progestin replacement therapy has no association with ovarian cancer until other large studies specifically assess ovarian cancer risk among persons with short-term or long-term estrogen/progestin replacement therapy use," they write. In an interview with Reuters Health, Dr. Kenneth L. Noller of Tufts University and the New England Medical Center in Boston, Massachusetts, who wrote an accompanying editorial, said that there is no obvious biological explanation for why estrogen might cause ovarian cancer. "In general, this is one of those times when we have an observation without a good biological basis," he said. "There seems to be a clear-cut increase in ovarian cancer, but we really don't know why." The finding is especially puzzling given that long-term use of oral contraceptives, which contain hormones similar to HRT, can reduce the risk of ovarian cancer, he noted. He emphasized that the increased cancer risks reside with women who take HRT for long periods of time. As such, women who have "terrible menopausal symptoms should not be afraid to take HRT for a short period of time," he said. However, for women with less severe symptoms, the answer is less clear. "With all of the new information about HRT, it seems to me that we must take a new approach to its use," Noller said. SOURCE: The Journal of the American Medical Association 2002;288:334-341, 368-369.

Hi, Susan! I was wondering how Bernie was doing...

http://story.news.yahoo.com/news?tm....es_dc_1 New Cause of Inherited Low Thyroid Disorder Found Thu Jul 11, 9:28 AM ET By Alison McCook NEW YORK (Reuters Health) - Changes in one gene involved in the synthesis of thyroid hormone may explain some cases of inherited hypothyroidism, or abnormally low levels of thyroid hormone, Dutch researchers report. The investigators found that a child with a severe thyroid hormone deficiency had inherited mutated forms of both copies of a gene called thyroid oxidase 2 (THOX2), which is involved in the process of producing thyroid hormone. Furthermore, three of eight patients with milder, temporary forms of the condition carried one mutated and one normal copy of THOX2. "We have found a new cause of congenital hypothyroidism," lead author Dr. Jose C. Moreno of the University of Amsterdam in the Netherlands told Reuters Health. The thyroid is a gland in the neck that regulates heart rate, metabolism, growth, mental function, energy and mood. During the first months of life, babies need a lot of thyroid hormone to help their brain develop and mature. However, after around 6 months, the need for thyroid hormone drops significantly, and falls to normal, adult levels a few years later. Hypothyroidism, the most common form of inherited endocrine disorder, is diagnosed in 1 of every 3,000 to 4,000 babies. The condition is treated by administering extra doses of thyroid hormone. In some patients born with permanent or temporary hypothyroidism, doctors can pinpoint the cause of the disorder, but in many cases, there is no clear explanation. In the present study, published in the July 11th issue of The New England Journal of Medicine ( news - web sites), Moreno and his team performed DNA analysis on nine patients with unexplained congenital hypothyroidism and their relatives. The researchers found that four of the nine patients carried mutations in the THOX2 gene that affect the functioning of the protein it encoded. However, in the five remaining patients, all of whom carried the mild, transient form of the disease, the investigators did not identify any genetic links to their condition. In an interview with Reuters Health, Moreno said that this lack of finding does not mean no genetic link exists. "It might be that these five kids have mutations in genes that have not yet been discovered," he suggested. One striking aspect of these results is that even a temporary form of hypothyroidism can have a genetic basis, Moreno added. Having only one good copy of THOX2 means patients produce lower than needed amounts of thyroid hormone, a problem that seems to disappear later in life once the patient's need for thyroid hormone decreases. However, the genetic defect that caused the condition never disappears, and some patients may experience a resurgence in symptoms at some point during adulthood, such as during pregnancy, when mothers need more thyroid hormone to feed the brain of the developing fetus, Moreno noted. Currently, children diagnosed with hypothyroidism are given thyroid hormone for many years. However, if they have only one mutated copy of THOX2, their need for extra hormone may significantly decrease earlier in life. These results may help identify those infants who will no longer need extra doses of the drug after the first several months of life, Moreno said. And, of course, researchers may one day be able to correct the genetic defect that is causing the condition. "Gene therapy--replacing defective copies of genes by normal genes--remains a possibility in the long-term perspective," Moreno noted. SOURCE: The New England Journal of Medicine 2002;347:95-102.

Sunday July 14, 11:33 am Eastern Time Press Release SOURCE: Newsweek Newsweek Cover: 'Beyond Hormone Therapy' Alternatives to Estrogen Include Diet Changes, Exercise, Cutting Back on Caffeine and Alcohol NEW YORK, July 14 /PRNewswire/ -- For many women who choose to stop taking hormone replacement therapy, a host of options are available to treat menopausal symptoms and help ward of disease, reports General Editor Claudia Kalb in the July 22 issue of Newsweek (on newsstands Monday, July 15). From diet and exercise changes to herbs and medications, women have many alternatives to estrogen. The age of one-stop shopping may be over, but a new tailored approach to treatment could be even better for women's health in the long run. For decades, women were told that hormone replacement therapy (HRT) would protect their hearts and preserve their youth. But when federal health officials announced last week that HRT drugs cause significantly more harm than good when taken for long periods, the results sparked a near panic among the estimated 13 million American women now using the drugs. Still, the news may have positively illuminated a fact that could improve future treatment: every woman experiences menopause differently, some sail through, while others spiral into a sweaty, moody exhaustion. "We can never look for one golden scientific truth," says Dr. Christine Northrup***, a holistic gynecologist. "One size does not fit all and never will." While there are few, if any, long-term conclusive studies on HRT alternatives to combat the symptoms of menopause, some women have noticed improvements after trying other options, some of them quite simple. Cutting back on spicy foods, caffeine and alcohol, and increasing aerobic exercise, vitamin E and soy (through foods like tofu and soy milk) can reduce hot flashes. And herbs have been used for hot flashes and night sweats for years. Foods rich in calcium -- milk, nuts, and dark leafy vegetables -- build bone density. And a diet low in saturated fats lowers the risk of cancer and helps reduce cholesterol levels, protecting against heart disease. Still, last week's findings don't rule out the use of the drug as a short-term remedy for menopausal symptoms and they don't apply to women who take estrogen without progestin following hysterectomy. But for millions of women, juggling the pros and cons of long-term HRT, the new findings offer something virtually unprecedented, which is clarity, report Senior Editor Geoffrey Cowley and Correspondent Karen Springen. But how could it take so long to assess the risks of estrogen? "The incestuous relationship between the pharmaceutical companies and the medical establishment is part of it," says Dr. Susan Love***, a prominent women's health specialist and longtime critic of HRT. "A lot of information doctors get is channeled through the companies. I would bet the average doctor thought this was already proven." *** Power Surge guests - read their transcripts in the Power Surge Library at http://www.power-surge.com/library.htm